1. Cannabinoid signaling in health and disease.
- Author
-
Lu Y and Anderson HD
- Subjects
- Affect drug effects, Analgesics administration & dosage, Analgesics adverse effects, Analgesics therapeutic use, Animals, Appetite Regulation, Canada, Cannabinoid Receptor Agonists metabolism, Cannabinoid Receptor Agonists pharmacology, Cannabinoid Receptor Antagonists pharmacology, Cannabinoids adverse effects, Cardiovascular System drug effects, Cardiovascular System metabolism, Central Nervous System drug effects, Central Nervous System metabolism, Humans, Medical Marijuana administration & dosage, Medical Marijuana adverse effects, Medical Marijuana therapeutic use, Multiple Sclerosis, Neoplasms drug therapy, Neoplasms metabolism, Neurodegenerative Diseases drug therapy, Neurodegenerative Diseases metabolism, Pain drug therapy, Pain metabolism, Signal Transduction, Sleep drug effects, Vomiting drug therapy, Vomiting metabolism, Amidohydrolases metabolism, Cannabinoids pharmacology, Cannabis chemistry, Endocannabinoids metabolism, Endocannabinoids physiology, Receptors, Cannabinoid metabolism
- Abstract
Cannabis sativa has long been used for medicinal purposes. To improve safety and efficacy, compounds from C. sativa were purified or synthesized and named under an umbrella group as cannabinoids. Currently, several cannabinoids may be prescribed in Canada for a variety of indications such as nausea and pain. More recently, an increasing number of reports suggest other salutary effects associated with endogenous cannabinoid signaling including cardioprotection. The therapeutic potential of cannabinoids is therefore extended; however, evidence is limited and mechanisms remain unclear. In addition, the use of cannabinoids clinically has been hindered due to pronounced psychoactive side effects. This review provides an overview on the endocannabinoid system, including known physiological roles, and conditions in which cannabinoid receptor signaling has been implicated.
- Published
- 2017
- Full Text
- View/download PDF